Stay up to date with the latest research in emergency and acute care. Our journal club posts critically appraise new studies, discuss their clinical relevance, and explore how evidence can inform practice.
Can clinicians identify life threatening injury in trauma patients? Probably not as reliably as we would wish according to this paper from London. Even in an experienced high performing EHPC team it’s tricky to discern which patients have life threatening, limb threatening or significant bleeding injuries. #FOAMed @stemlyns
Can clinical examination identify life-threatening injuries? Read More
The TOP-ART trial of Artesunate in the treatment of bleeding trauma patients. This RCT shows no benefit and potential harm, but it may be more complex than that. Further work may be needed on immunomodulation in bleeding trauma patients.
TOP-ART study: Artesunate for bleeding trauma patients Read More
Zaf Qasim @resusone reviews the UKREBOA trial. No benefit shown, but is this really the end of REBOA in trauma? #FOAMed @stemlyns
The UK-REBOA trial – Has the balloon popped? Read More
Critical appraisal of the DEVICE trial as published in 2023 NEJM. VL outperforms DL in this study of critically unwell patients.
Video Laryngoscopy vs Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults Read More
Semi-structured interviews are a great way to get the really rich data we need to understand something in greater depth. They allow us to ask ‘why?’ as well as just ‘what?’, ‘who?’ and ‘when?’.
Semi Structured Interviews (CAN9) Read More
Listen to the latest St Emlyn’s podcast and learn more about dual sequence defibrillation, concussion and the #stemlynsWILD program. Don’t forget to subscribe.
Podcast – January 2023 Monthly Round Up Read More
the use of Extracorporeal Cardiopulmonary Resuscitation (ECPR) has been considered by many resuscitationists as the next logical step in the management of cardiac arrest. But is it?…
ECPR for refractory cardiac arrest Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
High dose vs. Low dose steroids in hospitalised COVID 19 patients. St Emlyn’s. Read More
